New drug cocktails aim to beat river blindness

NCT ID NCT06070116

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests four different drug combinations in 300 adults with onchocerciasis (river blindness), a parasitic disease. Participants first receive ivermectin to clear skin and eye parasites, then get one of the new combos. The goal is to see which combo is safest and most effective at killing adult worms and preventing disease spread.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Ivermectin, Albendazole, Diethylcarbamazine, Moxidectin

What this could lead to

If successful, these drug combinations could offer safer and more effective treatments for river blindness, potentially reducing the need for repeated doses.

What could go wrong

This is a phase 2 trial with 300 participants, so results are still early. The new combinations may cause side effects or not work better than existing treatments.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ONCHOCERCIASIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

ocular onchocerciasis onchocerciasis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Bong County Hospital

    Bong Town, Bong County, Liberia